Anthracyclines are an effective chemotherapy agent. However, very few cases of idarubicin-induced cardiomyopathy exist. Herein, we describe a case of first-dose idarubicin-related acute heart failure in a woman with a history of myelodysplastic syndrome converted to acute myeloid leukaemia.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536188 | PMC |
http://dx.doi.org/10.1136/bcr-2018-228149 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!